141 related articles for article (PubMed ID: 9162692)
1. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
2. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
3. [Increased risk of occurrence of pulmonary adenocarcinoma in man is associated with the presence of rare alleles of the Hras1 minisatellite].
Gaspar'ian AV; Zborovskaia IB; Mukeriia AF; Tatosian AG; Zaridze DG
Genetika; 1998 Nov; 34(11):1537-41. PubMed ID: 10096029
[TBL] [Abstract][Full Text] [Related]
4. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
Vachtenheim J; Horáková I; Novotná H
Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
[TBL] [Abstract][Full Text] [Related]
6. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.
Sugimura H; Caporaso NE; Modali RV; Hoover RN; Resau JH; Trump BF; Longergan JA; Krontiris TG; Mann DL; Weston A
Cancer Res; 1990 Mar; 50(6):1857-62. PubMed ID: 2407346
[TBL] [Abstract][Full Text] [Related]
7. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
8. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
9. [Allelotyping the Hras1 minisatellite: formation of carcinogenic risk groups and predicting the course of non-small cell lung cancer].
Chizhikov VV; Gaspar'ian AV; Zborovskaia IB
Genetika; 2001 Oct; 37(10):1388-95. PubMed ID: 11761616
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
11. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.
Iizasa T; Baba M; Saitoh Y; Suzuki M; Haga Y; Iyoda A; Chang H; Hiroshima K; Itoga S; Tomonaga T; Nomura F; Fujisawa T
Oncol Rep; 2005 Oct; 14(4):919-23. PubMed ID: 16142352
[TBL] [Abstract][Full Text] [Related]
13. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
14. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
15. [Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers].
Cheng JQ; Crépin M; Hamelin R
C R Acad Sci III; 1990; 311(5):175-9. PubMed ID: 2169974
[TBL] [Abstract][Full Text] [Related]
16. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
17. [The role of the constitutional features and rearrangement of the H-ras 1 oncogene in the development of human lung cancer].
Nikiforova IF; Maksimishina MG; Lemekhov VG; Kniazev PG
Vopr Med Khim; 1991; 37(6):64-8. PubMed ID: 1687495
[TBL] [Abstract][Full Text] [Related]
18. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
20. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
